Clinical Trial Update: CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating how the dialyzability of beta blockers affects cardiovascular outcomes in patients with end-stage kidney disease; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: End-Stage Kidney Disease, End-Stage Renal Disease | Phase 3 | Status: RECRUITING